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Abstract
Background: The staphylococci are one of the most common environmental isolates found in clean room facility.
Consequently, isolation followed by comprehensive and accurate identification is an essential step in any
environmental monitoring program.
Findings: We have used the API Staph identification kit (bioMérieux, France) which depends on the expression of
metabolic activities and or morphological features to identify the Staphylococcus isolates. The API staphylococci
showed low sensitivity in the identification of some species, so we performed molecular methods based on PCR
based fingerprinting of glyceraldehyde-3-phosphate dehydrogenase encoding gene as useful taxonomic tool for
examining Staphylococcus isolates.
Conclusions: Our results showed that PCR protocol used in this study which depends on genotypic features was
relatively accurate, rapid, sensitive and superior in the identification of at least 7 species of Staphylococcus than API
Staph which depends on phenotypic features.
Background
In aseptic processing, one of the most important labora-
tory controls is the environmental monitoring program.
This program is a defined, documented program that
describes the routine particulate and microbiological
monitoring of processing and manufacturing areas and
includes a corrective action plan when action levels are
exceeded. Environmental monitoring should promptly
identify potential routes of contamination, allowing for
implementation of corrections before product contami-
nation occurs through evaluating the quality of air and
surfaces in the clean room environment. The monitoring
program should cover all production shifts and should
include air, floors, walls, and equipment surfaces, includ-
ing the critical surfaces that come in contact with
the product, container, and closures. Samples should be
taken throughout the classified areas of the aseptic pro-
cessing facility (e.g., aseptic corridors, gowning rooms)
using scientifically sound sampling procedures. Sample
sizes should be sufficient to optimize detection of envir-
onmental contaminants at levels that might be expected
in a given clean area.
It is important that locations posing the most microbio-
logical risk to the product be a key part of the program. It
is especially important to monitor the microbiological
quality of the critical area to determine whether or not
aseptic conditions are maintained during filling and clos-
ing activities. Air and surface samples should be taken at
the locations where significant activity or product expo-
sure occurs during production. Critical surfaces that come
in contact with the sterile product should remain sterile
throughout an operation. Critical surface sampling should
be performed at the conclusion of the aseptic processing
operation to avoid direct contact with sterile surfaces dur-
ing processing. Detection of microbial contamination on a
critical site would not necessarily result in batch rejection.
Environmental monitoring of critical and controlled
areas must include a comprehensive viable monitoring pro-
gram which considers the following: frequency of sampling,
time at which the samples are taken (i.e., during or at the
conclusion of operations), duration of sampling, sample
size (e.g., surface area, air volume), specific sampling
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appropriate response to deviations from alert or action
levels.
The staphylococci are one of the most common bac-
terial isolates found in clean room facilities. Staphylo-
cocci are the causative agents of many opportunistic
human and animal infections and are considered among
the most important pathogens isolated in the clinical
microbiology laboratory [1]. Coagulase-negative staphy-
lococci (CNS) represent the majority of the species and
are considered to be saprophytic or potentially patho-
genic. Several species of the CNS have been involved in
nosocomial infections related to implanted medical
devices such as intravenous catheters, prosthetic heart
valves and orthopedic implants. The species that most
frequently cause diseases are Staphylococcus epidermidis,
Staphylococcus haemolyticus and Staphylococcus sapro-
phyticus. Other significant opportunistic pathogens
include Staphylococcus hominis, Staphylococcus warneri,
Staphylococcus capitis, Staphylococcus simulans, Staphy-
lococcus cohnii, Staphylococcus xylosus, Staphylococcus
saccharolyticus, and Staphylococcus lugdunensis [2,3].
Consequently, isolation followed by comprehensive
and accurate identification of the distinct Staphylococcus
species is of extreme importance in order to initiate the
proper antibiotic therapy. Several methods for the iden-
tification of Staphylococcus spp. have been proposed.
These methods usually detect traditional phenotypic
properties and are available in miniaturized form for
automation and convenience. The identification meth-
ods now in use range from the fully automated identifi-
cation and susceptibility test systems such as the VITEK
2 (bioMérieux, France) and the BD Phoenix system
(Beckton Dickinson, MD, USA) to the API Staph identi-
fication kit (bioMérieux, France) [4-6]. In addition to
the previous methods, gas-liquid chromatography analy-
sis of cellular fatty acids is also used [7]. However,
methods based on phenotypic characterization are ham-
pered by the fact that they depend on the expression of
metabolic activities and or morphological features and
consequently, many isolates are still poorly identified
and supplementary methods are often required for com-
plete and accurate identification.
Molecular methods such as PCR-based fingerprinting
have been also used successfully for Staphylococcus iden-
tification at the species level [8-12]. PCR amplification of
the 16 S rRNA gene, sodA and the glyceraldehyde-3-
phosphate dehydrogenase gap gene has been reported
[13-19]. It has been described that Staphylococcus aureus
as well as number of coagulase-negative staphylococci,
including Staphylococcus epidermidis, Staphylococcus
capitis, Staphylococcus haemolyticus and Staphylococcus
hominis have a 42-kDa transferrin-binding protein (Tpn)
in common, located within cell wall. This protein is a
member of the newly emerging family of multifunctional
cell wall-associated glyceraldahyde-3-phosphate dehydro-
genases which catalyze the conversion of glyceraldehyde-
3-phosphate to 1, 3 diphosphoglycerate and incorporate
binding sites for both transferrin and the serine protease
plasmin [20-23]. Although the gene product in both
Staphylococcus saprophyticus and Staphylococcus war-
neri, is unable to bind to human transferrin [22], the gap
gene sequence can still be amplified by PCR. Analysis of
the gap gene represents a high-throughput reproducible
method that allows identification of distinct Staphylococ-
cus species [23].
In this paper we describe a high-throughput and rapid
identification method using both API Staph identifica-
tion system followed by PCR analysis of the gap gene,
for various Staphylococcus species isolated from envir-
onmental samples taken from air, surface, and person-
nel (filling, filtration and sterility areas) as a part of
routine environmental monitoring program in pharma-
ceutical clean room facility at VACSERA (Holding
Company for Biological Products & Vaccines) labora-
tories in Giza, Egypt.
Materials and methods
Sampling methods for routine environmental monitoring
Active air sampling
By slit-to-agar (Biological air sampler, model STA-204,
New Brunswick scientific, NJ, USA) where air was
drawn through slit, which rotates across the surface of
an agar plate around central axis. The speed of rotation
was set so that the whole surface of the plate was cov-
ered within one hour [24-26].
Passive air sampling
Settling plates (Petri dishes containing nutrient growth
medium exposed to the environment for one hour) were
used [27,28].
Surface and personnel sampling
Standard contact plates (RODAC: Replicate Organism
Detection and Counting) were used. The convex agar
meniscus allowed direct application to test surfaces (e.g.
walls, floors, equipment) for hygiene control and per-
sonnel locations(hands, chest and mask). The medium
used contained neutralizing agents, which inactivated
any residual disinfectants on the surface to be tested
and therefore enabled comparative results before and
after cleaning [29-32].
Sampling conditions
Sampling was carried out in the operational state with
process equipment running and personnel performing
normal operations and in a specified condition. Sam-
pling did not interfere with critical work zone protection
or compromise the quality of any products prepared
that was administered to patients. The operational con-
dition for unidirectional airflow cabinets/isolators and
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was working in any part of the clean air device. Sam-
pling at the rest of the facility condition was continued
at an agreed frequency to monitor baseline contamina-
tion levels. The operational conditions and the activities
being performed at the time of testing were recorded.
Sampling locations
Samples were taken from air, surface and personnel fill-
ing, filtration and sterility laboratory areas. Care was
taken that samples were taken from critical and adjacent
areas.
Culture media used
Environmental monitoring samples were grown on
Tryptone Soy Agar medium, (TSA), (Bacto, France).
The media was modified and contained neutralizing
agents (sodium thiosulphate and lecithin) to inactivate
residual surface disinfectant present on the surface to be
tested.
Incubation conditions
Plates were incubated at 30°C - 35°C (inverted) for at
least 2 days to detect bacteria and at 20°C - 25°C for at
least 5 days to detect mould and fungi.
Interpretation of the test results
After appropriate incubation, microbiological contamina-
tion was detected by observing colonies that were enumer-
ated as colony forming units (cfu) on each plate. Separate
colony counts were tabulated for mould and bacteria.
Note: For plates used in the slit to agar sampler, cfu
reading was corrected to cfu/m
3 according to standar-
dized equations.
Bacterial strains and growth conditions
Bacterial strains used in thi ss t u d yw e r ei s o l a t e df r o m
air, surface, and personnel in a pharmaceutical clean
room and were kept at -80°C in glycerol stock form.
Reference strains used PCR amplification of gap gene
were Staphylococcus aureus ATCC 6538 used as positive
control and Pseudomonas aergenosa ATCC 9027 used
as a negative control.
Identification of environmental isolates by commercial
Identification system API Staph
Preparation of the Strip was done following the standard
procedure (bioMérieux, France). Briefly, strains were sub-
cultured on Columbia Blood Agar (or P Agar), (Oxoid,
England), 18-24 hours at 37°C, and checked for purity. All
isolates were subjected to Gram stain to check for mor-
phology and to confirm that they belong to the Micrococ-
caceae family. A homogenous suspension of each bacterial
isolate was prepared in the supplied API Staph medium
with turbidity corresponding to 0.5 McFarland standard.
The suspension was used immediately.
The micro-tubes of the API strip were filled with the
bacterial suspension; mineral oil was added to the micro-
tubes that needed to be incubated under anaerobic
conditions. The lid was placed and the incubation box
(lid and tray) was incubated at 37°C for 20-24 hours.
After the incubation period the color was observed in
each micro-tube and compared to the negative control.
Appropriate reagents were added as required to certain
reaction and as described by the kit manual. Identifica-
tion was carried using the API Staph identification soft-
ware (bioMérieux, France).
Chromosomal DNA isolation
One loopful from each glycerol stock of each isolate was
streaked on TSA (Tryptic Soy Agar), (Bacto, France),
plate to obtain well isolated colonies. Plates were incu-
bated at 35°C - 37°C for 18-24 h. After incubation, one
colony was inoculated into 3 ml LB broth and incubated
overnight at 37°C. On the next day, the cultures were
centrifuged at 4,000 g for 10 minutes at room tempera-
ture. Genomic DNA was extracted by using the EaZy
Nucleic Acid Isolation Bacterial DNA Kit (Omega Bio-
tech) following the instructions manual. The final DNA
was eluted with water and the concentration of the DNA
was determined at 260 nm using the spectrophotometer
(Biotech Engineering, 80 DV UV/VIS, UK).
PCR analysis
PCR amplification reactions were performed using a pair
of primers selected on the basis of the gap gene nucleo-
tide sequence of Staphylococcus aureus (933-bp long,
from the Genbank database under accession number
AJ133520). A 26-nucleotide forward primer: GF-1
(5’-ATGGTTTTGGTAGAATTGGTCGTTTA-3’), corre-
sponding to positions 22 to 47 of the gap gene, and a
25-nucleotide reverse primer, GR-2 (5’- GACATTTCGT-
TATCATACCAAGCTG-3’), corresponding to positions
956 to 932 were selected. Primers were synthesized by
(Alpha DNA, Montreal, Quebec, Canada). PCR amplifi-
cation was carried out using DNA thermal cycler (Eppen-
dorf, Gradient, Hamburg, Germany) by using PCR kit
(PuReTaq Ready-To-Go™ PCR Beads from GE Health-
care, USA) following the manufacturer instructions.
Briefly, the reaction contained 100 pmoles of each primer
(in 0.1 μl volumes), 0.75 to 1 μg of template DNA (in 1 μl
volumes), added to one tube of stable beads and water to
25 μl. The stable beads contain stabilizers, BSA (Bovine
Serum Albumin), (dATP, dCTP, dGTP, and dTTP), ~ 2.5
units of pure Taq DNA polymerase and reaction buffer.
DNA was denatured at 94°C for 10 minutes. This was fol-
lowed by 40 cycles of DNA denaturation at 94°C for
30 sec, primer annealing at 55°C for 30 sec and extension
at 72°C for 1 min. After the final cycle, reactions were
terminated by an extra cycle at 72°C for 5 minutes. To
visualize the product, 8 μl of each PCR reaction were
mixed with 3 μl 6× loading dye (GenBioscience) and
loaded on 1% Agarose gel: (Metaphor Agarose) was used
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A 100 bp DNA ladder (GenBioscience) was used as a
marker.
Statement of Ethical Approval
All experiments, involving any samples taken from per-
sonnel and done in this study, were done in accordance
and approval of the ethical committee at Cairo Univer-
sity, Cairo, Egypt.
In addition, all personnel who contributed any sam-
ples, (swabs or any other form), did this according to
their informed consent.
Results and Discussion
Identification of environmental isolates from air, surface,
personnel by using API Staph system:
A total of 43 isolates were tested using the API Staph
test system (biomerieux, France). 23 isolates were taken
from surfaces of filling areas (filling machine panels),
sterility area (Laminar Air Flow Buttons).15 isolates
were taken from active air filling areas (filtration, filling,
capping, sterility and Fedagarie room (autoclave room
used for sterilization of gowns and different items used
in the production process).F i v es a m p l e sw e r et a k e n
from personnel. The isolates were taken according to a
routine environmental monitoring program.
Most of the isolates drawn from surface represent 65%
of total isolates; the samples comply with the European
commission guide due to GMP.
The result of the API Staph identification showed that
among the 23 isolate taken from surfaces almost half of
them (12 isolates) were identified as Staphylococcus
hominis, three isolates were identified as Staphylococcus
epidermidis, two isolates of each of Staphylococcus xylo-
sus and Staphylococcus aureus, and one isolate of each
of Staphylococcus warneri, Staphylococcus sciuri, Staphy-
lococcus lugdunensis, and Staphylococcus haemolyticus.
Among the 15 samples taken from air, more than half
(8 isolates) were identified as Staphylococcus hominis,
four isolates were identified as Staphylococcus haemoly-
ticus, and one of each of Staphylococcus epidermidis,
Staphylococcus lugdunensis and Staphylococcus warneri.
Isolates taken from personnel were identified as two
being Staphylococcus hominis, two isolates as Staphylo-
coccus epidermidis and one isolate as Staphylococcus
aureus
The result of the API Staph identification is summar-
ized in table 1 which shows the different species of Sta-
phylococcus isolated from each main source (surface,
personnel or air) and the % identity of each isolate.
The result shows that almost half of the total isolates
(22 isolates) regardless of origin were identified as Sta-
phylococcus hominis, a coagulase-negative member of
the bacterial genus Staphylococcus.
Staphylococcus hominis occurs very commonly as a
harmless commensal on human and animal skin, which
explains its abundance among the isolates from different
sources. However, like many other coagulase-negative
staphylococci, S. hominis may occasionally cause infec-
tion in patients whose immune system is compromised,
for example by chemotherapy or predisposing illness.
A total of six isolates were identified as Staphylococcus
epidermidis which is also coagulase-negative and occurs
frequently on the skin of humans and animals and in
mucous membranes. Due to contamination, S. epidermi-
dis is probably the most common species found in
laboratory tests which explains its abundance among the
isolates. S. epidermidis is usually non-pathogenic, it is an
important cause of infection in patients whose immune
system is compromised, or who have indwelling cathe-
ters. Many strains produce a biofilm that allows them to
adhere to the surfaces of medical prostheses.
A total of five isolates were identified as Staphylococcus
haemolyticus a coagulase-negative, and catalase positive
staphylococci, frequently found as a commensal organism
on the skin of humans and animals, S. haemolyticus
occurs infrequently as a cause of soft-tissue infections,
usually in immunocompromised patients.
S. haemolyticus is resistant to multiple antimicrobial
agents. Resistance to vancomycin has been recorded, and
this is a cause for concern because such resistance could
be acquired by other, more pathogenic staphylococci [33].
Three isolates were identified as Staphylococcus aur-
eus, the most common cause of Staph infections. It is
frequently living on the skin or in the nose of a person.
Approximately 20-30% of the general populations are
“Staph carriers”.
Staphylococcus aureus can cause a range of illnesses
from minor skin infections, such as pimples, impetigo,
boils, cellulites, furuncles, carbuncles, scalded skin syn-
drome and abscesses, to life-threatening diseases, such
as pneumonia, meningitis, osteomyelitis, endocarditis,
toxic shock syndrome (TSS), and septicemia [34].
Table 1 Different species of Staphylococcus and their %
identity
API Identification Number of isolates % identity
Staphylococcus hominis 22 47.3%-80%
Staphylococcus epidermidis 6 89%-97.8%
Staphylococcus haemolyticus 5 41%-89.9%
Staphylococcus aureus 3 69%-99%
Staphylococcus lugdunensis 2 42%-64.7%
Staphylococcus warneri 2 38%-74.7%
Staphylococcus xylosus 2 90%-99.8%
Staphylococcus sciuri 1 27.3%
Total 43
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S. xylosus, S. warneri, S. lugdunensis and S. sciuri are all
common commensals on human skin and mucous mem-
branes. Consequently, the identity of the Staphylococcus
isolates showed a typical distribution in an environmental
sample with the majority of the isolates being those com-
monly found as commensals on skin surfaces.
35 out of the 43 isolates (81%) identified using API
Staph identification system showed identity range
between (57.1%-99.8%). Although the majority of the iso-
lates were in a “good identification” range (70%), several
isolates showed a relatively weak or poor identification.
We decided to investigate the clones on a molecular level
by attempting to amplify the glyceraldehyde-3-phosphate
Figure 1 PCR products of isolates numbered 1 to 22. Agarose gel electrophoresis of 933-bp PCR amplification products from chromosomal
DNA from staphylococcal species using primers GF-1 and GR-2, M: Ladder marker, black arrow refers to the correct size product of the gap gene
corresponding to 933 base pairs. +ve: Staphylococcus aureus ATCC 6538,-ve: Pseudomonas aeruginosa ATCC 9027. Samples 1-22 except 3&4:
Staphylococcus hominis,3 :Staphylococcus aureus and 4: Staphylococcus sciuri.
Figure 2 PCR products of isolates numbered 23 to 45. Agarose gel electrophoresis of 933-bp PCR amplification products from chromosomal
DNA from staphylococcal species using primers GF-1 and GR-2, M, +ve, -ve and black arrow are the same as in figure 1. Samples 23, 45:
Staphylococcus hominis, 24-29: Staphylococcus epidermidis, 30, 31: Staphylococcus aureus, 32, 33: Staphylococcus lugdunensis, 34, 35: Staphylococcus
warneri, 36, 37: Staphylococcus xlyosus and 38-42: Staphylococcus haemolyticus.
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a very well conserved gene that can be used as a useful
tool in PCR assays for identification of Staphylococcus
species [15]. The gap gene product glyceraldehyde-3-
phosphate dehydrogenase has been discovered to be
located within the cell walls of S. aureus and other coagu-
lase-negative staphylococci. The pair of primers used in
this study successfully primed the synthesis of a 933 bp
fragment corresponding to the gap gene. All the isolates
gave the corresponding PCR band equivalent to the gap
gene product as seen after agarose gel electrophoresis
(Figures 1 and 2) confirming the identity of the isolates
as belonging to the genus Staphylococcus. All the Staphy-
lococcus species identified in our study (table 1) were
similarly identified with PCR amplification of the gap
gene in previous studies [15,19,35] confirming the repro-
ducibility, reliability and efficiency of the method.
In conclusion, we used the API Staph identification sys-
tem followed by PCR amplification of the gap gene to
identify various Staphylococcus species isolated from a
clean room environment. The methods showed a reliable
and rapid identification and can be used for the analysis
of large number of samples in a high-throughput manner.
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